Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Share-based Compensation (2016 - 2025)

Prestige Consumer Healthcare has reported Share-based Compensation over the past 16 years, most recently at $2.7 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $2.7 million for Q4 2025, down 4.4% from a year ago — trailing twelve months through Dec 2025 was $10.9 million (down 10.12% YoY), and the annual figure for FY2025 was $11.2 million, down 20.36%.
  • Share-based Compensation for Q4 2025 was $2.7 million at Prestige Consumer Healthcare, up from $1.8 million in the prior quarter.
  • Over the last five years, Share-based Compensation for PBH hit a ceiling of $4.1 million in Q2 2023 and a floor of $1.7 million in Q1 2022.
  • Median Share-based Compensation over the past 5 years was $2.7 million (2025), compared with a mean of $2.9 million.
  • Biggest five-year swings in Share-based Compensation: surged 105.38% in 2022 and later crashed 42.14% in 2024.
  • Prestige Consumer Healthcare's Share-based Compensation stood at $2.2 million in 2021, then grew by 8.91% to $2.4 million in 2022, then grew by 0.66% to $2.4 million in 2023, then rose by 16.99% to $2.9 million in 2024, then decreased by 4.4% to $2.7 million in 2025.
  • The last three reported values for Share-based Compensation were $2.7 million (Q4 2025), $1.8 million (Q3 2025), and $3.7 million (Q2 2025) per Business Quant data.